Munich, Germany – 10 December 2020 – Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) introduces the new EiceDRIVER™ 2EDL8 gate driver IC product family to foster the growth in DC-DC telecom bricks for mobile network infrastructure. These dual-channel junction-isolated gate driver ICs allow for high power density, high efficiency and robustness in isolated DC-DC step-down converters/telecom bricks enabling macro base stations for 5G and LTE telecom infrastructures.
The 2EDL8 family comprises four variants offering two different pull-up currents and two different input configurations. The 3 A version is ideally suited for retrofit designs, while the industry-leading 4 A version is recommended to reduce MOSFET switching losses.
The 2EDL802x permits both channels to operate independently. This device is the perfect choice for diagonally driven full-bridges on the primary side, as well as for the synchronous rectification stage on the secondary side to reduce the losses during the freewheeling phase. The 2EDL812x has a differential input structure and built-in shoot-through protection making it the perfect choice for non-diagonally driven primary-side half-bridge stages in DC-DC brick converters.
The 2EDL8 features an integrated 120 V bootstrap diode and precise channel-to-channel propagation delay matching of ± 2 ns typically. All products in the family have industry-standard PG-VDSON-8 leadless packages and pin-out.
Availability
All four product variants of the EiceDRIVER 2EDL family are available now. More information is available at www.infineon.com/2EDL8.
Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…
The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…
More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…
The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…
Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…
This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…